Investigation of Anti-Toxocara and Anti-Toxoplasma Antibodies in Patients with Schizophrenia Disorder

Table 2

Seropositivity of Toxoplasma gondii and Toxocara antibodies in patients with schizophrenia disorder and healthy controls.

	Patients’ group	Healthy	Sig	OR	CI95
	𝑁 (%)	𝑁 (%)
Toxoplasma gondii	34/100 (34%)	45/95 (47.36%)	0.08	0.57	0.32–1.02
Toxocara	14/100 (14%)	4/95 (4.3%)	0.02	0.27	0.08–0.8